相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-beta-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and Memory
M. Amin Khan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
D-Cycloserine Ameliorates Autism-Like Deficits by Removing GluA2-Containing AMPA Receptors in a Valproic Acid-Induced Rat Model
Han-Fang Wu et al.
MOLECULAR NEUROBIOLOGY (2018)
Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit
N. Yao et al.
MOLECULAR PSYCHIATRY (2018)
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling
L. Cavalleri et al.
MOLECULAR PSYCHIATRY (2018)
Involvement of neuronal and glial activities in control of the extracellular D-serine concentrations by the AMPA glutamate receptor in the mouse medial prefrontal cortex
Sayuri Ishiwata et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Negative Symptom Interventions in Youth at Risk of Psychosis: A Systematic Review and Network Meta-analysis
Daniel J. Devoe et al.
SCHIZOPHRENIA BULLETIN (2018)
The GlyT1 Inhibitor Bitopertin Ameliorates Allodynia and Hyperalgesia in Animal Models of Neuropathic and Inflammatory Pain
Anja Armbruster et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Potential and Challenges for the Clinical Use of D-Serine As a Cognitive enhancer
Gerson D. Guercio et al.
FRONTIERS IN PSYCHIATRY (2018)
Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
Chieh-Hsin Lin et al.
BIOLOGICAL PSYCHIATRY (2018)
The Discrimination Ratio derived from Novel Object Recognition tasks as a Measure of Recognition Memory Sensitivity, not Bias
Magali H. Sivakumaran et al.
SCIENTIFIC REPORTS (2018)
Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial
Chun-Yuan Lin et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2017)
Asc-1 Transporter Regulation of Synaptic Activity via the Tonic Release of D-Serine in the Forebrain
Hagit Sason et al.
CEREBRAL CORTEX (2017)
D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity
Donald C. Goff
CURRENT NEUROPHARMACOLOGY (2017)
Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway
Saki Shimizu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex
D. M. Bortz et al.
NEUROPHARMACOLOGY (2017)
Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging
Chieh-Hsin Lin et al.
SCIENTIFIC REPORTS (2017)
D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome
Elisa S. Na et al.
PLOS ONE (2017)
Major Developments in the Design of Inhibitors along the Kynurenine Pathway
Kelly R. Jacobs et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Challenges of Fear Conditioning Research in the Age of RDoC
Tina B. Lonsdorf et al.
ZEITSCHRIFT FUR PSYCHOLOGIE-JOURNAL OF PSYCHOLOGY (2017)
Competitive Inhibitors Unveil Structure/Function Relationships in Human D-Amino Acid Oxidase
Gianluca Molla
FRONTIERS IN MOLECULAR BIOSCIENCES (2017)
The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia
Peijun Ju et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2016)
GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice
Lakshmi Rajagopal et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions
Michael W. Otto et al.
BIOLOGICAL PSYCHIATRY (2016)
The dopamine D3-preferring D2/D3 dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia
David J. G. Watson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia
Philip L. R. Gaskin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
True alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence
Pascal J. D. Goetghebeur et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders
Mark J. Millan et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Altering the course of schizophrenia: progress and perspectives
Mark J. Millan et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Effects of the glycine reuptake inhibitors bitopertin and RG7118 on glycine in cerebrospinal fluid: results of two proofs of mechanism studies in healthy volunteers
Carsten Hofmann et al.
PSYCHOPHARMACOLOGY (2016)
Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme
Dragana Bugarski-Kirola et al.
LANCET PSYCHIATRY (2016)
The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond
Darrick T. Balu et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Inhibition of Glycine Transporter 1: The Yellow Brick Road to New Schizophrenia Therapy?
Philipp Singer et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex
Dominik Strzelecki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials
Y. Iwata et al.
MOLECULAR PSYCHIATRY (2015)
GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders
Jared W. Young et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia
Shigeyuki Chaki et al.
PSYCHOPHARMACOLOGY (2015)
D-serine levels in Alzheimer's disease: implications for novel biomarker development
C. Madeira et al.
TRANSLATIONAL PSYCHIATRY (2015)
A Trial of D-Cycloserine to Treat Stereotypies in Older Adolescents and Young Adults With Autism Spectrum Disorder
Maria Urbano et al.
CLINICAL NEUROPHARMACOLOGY (2014)
The Novel Object Recognition Test in Rodents in Relation to Cognitive Impairment in Schizophrenia
Lakshmi Rajagopal et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
In vitro Characterization of a small molecule inhibitor of the alanine serine cysteine transporter-1 (SLC7A10)
Jeffrey M. Brown et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Astroglial D-serine is the endogenous co-agonist at the presynaptic NMDA receptor in rat entorhinal cortex
Alex M. Lench et al.
NEUROPHARMACOLOGY (2014)
The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey
Donnie Eddins et al.
PSYCHOPHARMACOLOGY (2014)
Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat
Philip L. R. Gaskin et al.
PSYCHOPHARMACOLOGY (2014)
Two grams of sarcosine in schizophrenia - is it too much? A potential role of glutamate-serotonin interaction
Dominik Strzelecki et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Glix 13, a New Drug Acting on Glutamatergic Pathways in Children and Animal Models of Autism Spectrum Disorders
Annamaria Chiara Santini et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia A Randomized, Double-Blind, Proof-of-Concept Study
Daniel Umbricht et al.
JAMA PSYCHIATRY (2014)
Increasing effects of S-methyl-L-cysteine on the extracellular D-serine concentrations in the rat medial frontal cortex
Sayuri Ishiwata et al.
AMINO ACIDS (2013)
Is D-Cycloserine a Prodrug for D-Serine in the Brain?
Mao Horio et al.
BIOLOGICAL PSYCHIATRY (2013)
Serine racemase as a prime target for age-related memory deficits
J. -M. Billard
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies
Scott W. Woods et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
A novel liquid chromatography/tandem mass spectrometry method for the quantification of glycine as biomarker in brain microdialysis and cerebrospinal fluid samples within 5 min
Patrizia Voehringer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Neuronal D-Serine and Glycine Release Via the Asc-1 Transporter Regulates NMDA Receptor-Dependent Synaptic Activity
Dina Rosenberg et al.
JOURNAL OF NEUROSCIENCE (2013)
Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain
Robert J. Harvey et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
The NMDA receptor as a target for cognitive enhancement
Graham L. Collingridge et al.
NEUROPHARMACOLOGY (2013)
Glycine Transporter Type 1 Occupancy by Bitopertin: a Positron Emission Tomography Study in Healthy Volunteers
Meret Martin-Facklam et al.
NEUROPSYCHOPHARMACOLOGY (2013)
GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
Jeffrey Burgdorf et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Towards improved animal models for evaluating social cognition and its disruption in schizophrenia: The CNTRICS initiative
Mark J. Millan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: A meta-analysis of case control studies
Annelies Brouwer et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
D-cycloserine in Prelimbic Cortex Reverses Scopolamine-Induced Deficits in Olfactory Memory in Rats
Marta Portero-Tresserra et al.
PLOS ONE (2013)
A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on craving in cocaine-dependent individuals
Kimber L. Price et al.
PSYCHOPHARMACOLOGY (2013)
The atypical antipsychotic risperidone reverses the recognition memory deficits induced by post-weaning social isolation in rats
Allison L. McIntosh et al.
PSYCHOPHARMACOLOGY (2013)
5-HT6 receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms
S. Woods et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex
Pascal Fossat et al.
CEREBRAL CORTEX (2012)
5-HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
Julie Meffre et al.
EMBO MOLECULAR MEDICINE (2012)
A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease
Katsuya Harada et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Blockade of dopamine D3 but not D2 receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment
David J. G. Watson et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
Mark J. Millan et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia
Daniela Alberati et al.
NEUROPHARMACOLOGY (2012)
Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex
David J. G. Watson et al.
NEUROPSYCHOPHARMACOLOGY (2012)
From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
Bita Moghaddam et al.
NEUROPSYCHOPHARMACOLOGY (2012)
D-Cycloserine enhances spatial memory in spontaneous place recognition in rats
Takaaki Ozawa et al.
NEUROSCIENCE LETTERS (2012)
D-Cycloserine Facilitates Socially Reinforced Learning in an Animal Model Relevant to Autism Spectrum Disorders
Meera E. Modi et al.
BIOLOGICAL PSYCHIATRY (2011)
Animal models of schizophrenia
C. A. Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology
L. M. DeVito et al.
GENES BRAIN AND BEHAVIOR (2011)
Simultaneous quantification of D- vs. L-serine, taurine, kynurenate, phosphoethanolamine and diverse amino acids in frontocortical dialysates of freely-moving rats: Differential modulation by N-methyl-D-aspartate (NMDA) and other pharmacological agents
Alain Gobert et al.
JOURNAL OF NEUROSCIENCE METHODS (2011)
Oral administration of glycine increases extracellular serotonin but not dopamine in the prefrontal cortex of rats
Makoto Bannai et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2011)
Pharmacological characterization of social isolation-induced hyperactivity
Katrine Fabricius et al.
PSYCHOPHARMACOLOGY (2011)
The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat
Caitlin A. Jones et al.
PSYCHOPHARMACOLOGY (2011)
Effects of low-dose d-serine on recognition and working memory in mice
Patricia Bado et al.
PSYCHOPHARMACOLOGY (2011)
Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice
Karla Kopec et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Stereological brain volume changes in post-weaned socially isolated rats
Katrine Fabricius et al.
BRAIN RESEARCH (2010)
The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures
Mark J. Millan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects
M. Liem-Moolenaar et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Alterations in Brain Extracellular Dopamine and Glycine Levels Following Combined Administration of the Glycine Transporter Type-1 Inhibitor Org-24461 and Risperidone
Katalin Nagy et al.
NEUROCHEMICAL RESEARCH (2010)
Increased dopaminergic activity in socially isolated rats: An electrophysiological study
Katrine Fabricius et al.
NEUROSCIENCE LETTERS (2010)
d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats
Toshiharu Shimazaki et al.
PSYCHOPHARMACOLOGY (2010)
Object location memory in mice: Pharmacological validation and further evidence of hippocampal CA1 participation
Fabricio Luiz Assini et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Impairment in Long-Term Retention of Preference Conditioning in Schizophrenia
Ellen S. Herbener
BIOLOGICAL PSYCHIATRY (2009)
Blockade of dopamine D-3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D-1 receptor agonists, but not of D-2 antagonists
Florence Loiseau et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
EFFECTS OF SOCIAL ISOLATION REARING ON THE LIMBIC BRAIN: A COMBINED BEHAVIORAL AND MAGNETIC RESONANCE IMAGING VOLUMETRY STUDY IN RATS
M. I. Schubert et al.
NEUROSCIENCE (2009)
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia
Jared W. Young et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Increased Dopamine D2High Receptors in Rats Reared in Social Isolation
Madeleine V. King et al.
SYNAPSE (2009)
D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats
Jun-Ichi Karasawa et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine
Kenji Hashimoto et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas
Kenneth W. Perry et al.
NEUROPHARMACOLOGY (2008)
Behavioural and neurochemical effects of post-weaning social isolation in rodents - Relevance to developmental neuropsychiatric disorders
Kevin C. F. Fone et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
The Cognitive and Negative Symptoms in Schizophrenia, Trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments
Robert W. Buchanan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Selective increase in the extracellular D-serine contents by D-cycloserine in the rat medial frontal cortex
Takahisa Fujihira et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia
Inna Bendikov et al.
SCHIZOPHRENIA RESEARCH (2007)
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-I SSR504734, a potential new type of antipsychotic
R Depoortère et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Distinguishing separable domains of cognition in human and animal studies: What separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the Measurement and Treatment Research to Improve Cognition in Schizophrenia New Approaches Conference
KH Nuechterlein et al.
SCHIZOPHRENIA BULLETIN (2005)
Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type
G Neeman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation - an effect sensitive to NMDA receptor antagonism
MV King et al.
NEUROPHARMACOLOGY (2004)
Glycine binding primes NMDA receptor internalization
Y Nong et al.
NATURE (2003)
Impaired visual memory in rats reared in isolation is reversed by D-cycloserine in the adult rat
TS Johannesen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Increased cortical kynurenate content in schizophrenia
R Schwarcz et al.
BIOLOGICAL PSYCHIATRY (2001)
Effects of the partial glycine agonist D-cycloserine on cognitive functioning in chronic low dose MPTP-treated monkeys
JS Schneider et al.
BRAIN RESEARCH (2000)
分享论文
